In a reshaping market landscape for inhaled pharmaceuticals we focus on several indications. Our unique technology as such can be positioned as a corner stone in a new pulmonary drug formulation strategy. It will open new routes of pulmonary administration, where possible avoiding invasive routes.
It offers comfort and mobility and improved ease of use, resulting in greater efficacy, patient adherence and hence better outcomes.
We are looking for partners who will by their participation – also financially – support Gilbert’s technology in reaching our goal.
Interested in investing?
Gilbert Technologies is in the process of private placements for further research and development. Are you interested in this project and do you want to receive investors information, please request here our documentation.
• Lode B.V.
• NHL University of Applied Sciences
• University Medical Centre Utrecht
• TU Delft
Gilbert Technologies BV
P.O. Box 6
1400 AA Bussum – NL
Gilbert Technologies 2017